Items where authors include "Pezaro, C."

Export as [feed] Atom [feed] RSS
Number of items: 6.

Article

Vasudev, N.S. orcid.org/0000-0001-8470-7481, Ainsworth, G., Brown, S. et al. (24 more authors) (2023) Standard Versus Modified Ipilimumab, in Combination With Nivolumab, in Advanced Renal Cell Carcinoma: A Randomized Phase II Trial (PRISM). Journal of Clinical Oncology. ISSN 0732-183X

Vasudev, N.S. orcid.org/0000-0001-8470-7481, Ainsworth, G. orcid.org/0000-0002-9952-8440, Brown, S. orcid.org/0000-0002-7975-7537 et al. (24 more authors) (2023) Standard versus modified ipilimumab, in combination with nivolumab, in advanced renal cell carcinoma: a randomized phase II trial (PRISM). Journal of Clinical Oncology. JCO2300236. ISSN 0732-183X

Hogan, N., Li, H., Pezaro, C. et al. (3 more authors) (2017) Searching for a written patient feedback instrument for patient-medical student consultations. Advances in Medical Education and Practice, 2017 (8). pp. 171-178.

Pezaro, C., Mukherji, D., Tunariu, N. et al. (8 more authors) (2013) Sarcopenia and change in body composition following maximal androgen suppression with abiraterone in men with castration-resistant prostate cancer. British Journal of Cancer, 109 (2). pp. 325-331. ISSN 0007-0920

Book Section

Hossain, M., Pezaro, C., Walsh, J. et al. (2 more authors) (2019) Metabolic complications. In: Young, A., Board, R.E., Leonard, P., Cooksley, T., Stewart, A. and Michie, C., (eds.) Problem Solving in Acute Oncology. ebn Health , pp. 84-88. ISBN 9780995595439

Proceedings Paper

Brown, J.E. orcid.org/0000-0003-4960-3032, Handforth, C., Walsh, J. orcid.org/0000-0002-7122-2650 et al. (5 more authors) (2019) 857P - Baseline fracture risk in men with prostate cancer starting the STAMPEDE trial. In: Annals of Oncology. 44th ESMO Congress (ESMO 2019), 27 Sep - 01 Oct 2019, Barcelona, Spain. Elsevier BV , v334-v335.

This list was generated on Sun Mar 24 13:11:18 2024 GMT.